MoneyWorks4Me

Marksans Pharma receives EIR for Goa facility

09 Oct 2017 Evaluate

Marksans Pharma has received Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its Goa facility which was inspected between April 3 and April 7, 2017.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..